[
Beginning in December, some of your Independence patients may receive a
letter from FutureScripts®, our pharmacy benefits manager and an
independent company, explaining updated guidelines for contraceptive coverage.
The letter explains that beginning January 1, 2016, upon group renewal,
brand-name contraceptives that have a generic alternative will be covered with
standard cost-sharing. The affected drugs are:
- Beyaz®
- Depo-subQ provera 104TM
- Ella®
- Lo Loestrin®
- Minastrin®
- Ortho Tri-Cyclen® Lo
- Safyral®
Those brand-name contraceptives
without a generic alternative or generic
equivalent will continue to be covered at 100 percent. Likewise, generic
contraceptives will continue to be covered at 100 percent. Brand-name
contraceptives with generic equivalents will continue to be covered at standard
cost-sharing.
Members are advised to contact their provider to find out if a generic
alternative, generic equivalent, or any contraceptive drug that does not have
cost-sharing is appropriate for them. When applicable, please issue a new
prescription for the member.
For questions about pharmacy coverage, members can call the Pharmacy Benefit
telephone number on the back of their ID card.
FutureScripts and FutureScripts Secure are independent
companies that provide pharmacy benefits management services.
]